The largest database of trusted experimental protocols

20 protocols using calcium e test wako

1

Evaluating Osteogenic Maturation of hMSC/HUVEC Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sections (5-μm thick) of the hMSC/HUVEC constructs cultured for 50 days were prepared and von Kossa staining or Alcian blue staining were conducted. The stained areas of mineralized aggregates were measured using images from the CCD camera (DS-Fi2) equipped with a light microscope (ECLIPSE Ci; Nikon). Four sections from four different cell constructs were used in the quantitative analysis.
The hardness of the mineralized aggregate was measured for investigating osteogenic-maturation of the hMSC/HUVEC constructs. Briefly, hMSC/HUVEC constructs cultured for 50 days were embedded in paraffin and then cut to the core using a microtome. The consistencies of the fabricated tissues were evaluated for micro-Vickers hardness using a micro hardness testing machine (MicroWiZhard; Mitsutoyo, Kawasaki, Japan) (n = 5).
The amount of mineral deposition produced by hMSCs in the cell constructs was investigated using the methylxylenol blue (MXB) method (Calcium E-Test Wako; Wako). hMSC/HUVEC cell constructs (100:0–95:5) cultured for 50 days were washed with ultrapure water and dried using a dry-heat sterilizer (MOV-112S; Sanyo, Tokyo, Japan). Dried cell constructs were dissolved in 1 M HCl and mixed with MXB and monoethanolamine buffer. The calcium concentrations of the solutions were determined by measuring the absorbance at 595 nm (n = 4).
+ Open protocol
+ Expand
2

Measurement of Plasma Calcium Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
The plasma Ca concentration was measured using the Calcium E-Test Wako (Wako Pure Chemical, Osaka, Japan)6 (link).
+ Open protocol
+ Expand
3

Osteogenic Differentiation of ASCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
ASCs (passage 5) were seeded in triplicate in a 24-well plate (Falcon®) at a density of 4 × 104 in D/α medium. After 4 days, differentiation was carried out using osteogenic differentiation medium consisting of DMEM (Sigma-Aldrich) supplemented with 10% fetal bovine serum (Sigma-Aldrich), 50 μM ascorbic acid 2-phosphate (Sigma-Aldrich), 0.01 μM Deamethasone (Sigma-Aldrich) and 1% Antibiotic-Antimycotic (Gibco) for 21 days. Culture medium was replaced every 2–3 days. After induction was completed, the cell densities were determined using cck8.
Osteogenesis was assayed by calcium content in differentiated cells and matrix mineralization with Alizarin Red S staining. The total calcium content was determined by a colorimetric assay using Calcium E-Test Wako (Wako Pure Chemical Industries, Osaka, Japan) after eluted by 10% (w/v) Formic acid (Wako) [31] (link). By the same method as for adipogenesis, chondrogenic potential was evaluated by the values adjusted by standard cells.
+ Open protocol
+ Expand
4

Spectrophotometric Calcium Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three pellets (5 μL each) were mixed with 2.5 μL of 0.5 N HCl in a tube and left to stand for 10 min. Samples were centrifuged at 13,000 rpm for 5 min at 4 °C and the supernatant (2.5 μL) was transferred into a 96-well plate. The calcium concentration in the supernatant was spectrophotometrically determined at 595 nm by following the color development with a calcium assay kit (Calcium E-test Wako, Fujifilm Wako Pure Chemical Industries, Ltd., Osaka, Japan). All values were normalized against the cultivation area.
+ Open protocol
+ Expand
5

Serum Biomarkers of Bone Metabolism

Check if the same lab product or an alternative is used in the 5 most similar protocols
At 6 weeks of age, the blood was collected at 12:00 (noon). Bone Specific Alkaline Phosphatase (BAP) and tartrate-resistant acid phosphatase 5b (TRACP-5b) were measured using a specific enzyme immunoassay (CUSABIO BIOTECH, Ltd, Wuhan, China). The receptor activator of NF-κB ligand (RANKL) was measured using ELISA kit (R&D SYSTEMS, Minneapolis, MN, USA). Osteocalcin was measured using a MOUSE OSTEOCALCIN EIA KIT (Biomedical Tec Inc., Stoughton, MA, USA). Serum Ca level was measured using a calcium E-test WAKO (WAKO, Tokyo, Japan). β-estradiol (E2) was measured using an Estradiol EIA Kit (Cayman Chemical Co., Ann Arbor, MI, USA). IGF-1 was measured using an Assay Max Mouse IGF-1 ELISA kit (ASSAYPRO, St. Charles, MO, USA). Growth hormone (GH) was measured using a Rat/Mouse Growth Hormone ELISA kit (MILLIPORE, Billerica, MA, USA). Insulin was measured using a sensitive mouse insulin ELISA kit (Shibayagi, Gumma, Japan).
+ Open protocol
+ Expand
6

Serum Calcium and 1,25(OH)2D3 Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
The serum concentrations of total calcium (mg/dL) and 1,25(OH)2D3 (pg/mL) were assayed using the Calcium E-Test Wako (Fujifilm Wako Pure Chemical Co., Osaka, Japan) and 1,25(OH)2 D RIA kit FR (Fujirebio Inc., Tokyo, Japan), respectively, according to the manufacturer’s instructions.
+ Open protocol
+ Expand
7

Serum Biomarker Measurement Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum markers were measured using the following assay reagents: serum intact PTH, rat intact PTH ELISA kit (cat. no. 60-2500, Immutopics, Inc., San Clemente, CA, USA, RRID: AB_2827505); serum Ca, Calcium E-Test Wako (FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan); serum Pi, Phospha C-Test Wako (FUJIFILM Wako Pure Chemical Corporation); serum FGF23, FGF23 ELISA kit (cat. no. CY-4000, KAINOS Laboratories, Inc., Tokyo, Japan, RRID: AB_2782966); serum 25(OH)D direct day ELISA Kit (cat. no. KR2108, Immundiagnostik AG, Bensheim, Germany, RRID: AB_2927705); PINP, rat/mouse PINP EIA (cat. no. AC-33F1, Immunodiagnostic Systems Ltd, Boldon, UK, RRID: AB_2801263); and CTX, Rat Laps EIA kit (cat. no. AC-06F1, Immunodiagnostic Systems Ltd., RRID: AB_2801265).
+ Open protocol
+ Expand
8

Mineralization Assay of PPU7 and HUCPVC Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PPU7 was grown on a 12-well plate at an initial density of 3.16 × 104 cells/cm2. After incubation for 24 h, the mineralization medium was changed to the above mineralization medium containing 20% and 50% CM-PPU7 or CM-HUCPVC. The cells were cultured for up to 7 days. The mineralization was visualized by Alizarin Red S staining using the same method described above (see Section 2.5. Detection of mineralized nodules in HUCPVCs).
For the measurement of Ca concentration, each well on the plates was rinsed with PBS, and the calcium was dissolved in 0.5 mL of 0.5 N HCl with gentle rocking for 1 h. The calcium concentration in the eluate was determined using a calcium assay kit (Calcium E-test Wako, Wako Pure Chemical Industries, Ltd.) and by spectrophotometrically following the color development at 595 nm. All values were normalized against the cultivation area.
+ Open protocol
+ Expand
9

Serum Biomarker Measurement Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The serum PTH level was measured using a Rat Intact PTH ELISA kit (Immutopics, Inc., San Clemente, CA). The serum calcium, phosphate and BUN levels were measured using an auto analyzer (Hitachi High-Technologies Corporation., Tokyo, Japan) or the following test kits: the Calcium E-test WAKO, the Phospha C-test WAKO, or the Blood Urea nitrogen B-test WAKO (Wako Pure Chemical Industries, Ltd., Osaka, Japan).
+ Open protocol
+ Expand
10

Preparing Platelet-Rich Fibrin from Whole Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
WB samples were quickly centrifuged at 1500 rpm for 3 min to prepare plasma fraction, which were subjected to determine total free calcium levels using a commercial kit based on MXB method (Calcium E-test WAKO; Wako Pure Chemicals, Osaka, Japan).
Stored WB samples were then mixed intermittently with 200 μL (20 μL × 10 times) of 10% CaCl2 solution and centrifuged by a Medifuge centrifugation system to prepare PRF. When lower amounts of CaCl2 were added, PRF clots were less reproducibly prepared. When higher amounts of CaCl2 were added intermittently, or when the optimal amount of CaCl2 were added at once, PRF clots were never prepared (Kawase, unpublished observations).
The supernatant serum fractions were subjected to determine calcium and glucose levels as described above and using a commercial kit based on GOD method (Glucose CII-test WAKO; Wako Pure Chemicals). The serum fractions were also used to determine pH levels by pH indicators (MColorHast; EMD Millipore Corp., Billerica, MA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!